Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purification and comparative characterization of some catalytic properties of liver mitochondrial and cytosolic NAD-dependent malate dehydrogenase (NAD-
MDH
; EC 1.1.1.37) from normal rats and rats with experimental toxic
hepatitis
(ETH) have been carried out. It has been found that there are some differences in catalytic and regulatory properties of liver NAD-
MDH
from control animals and rats with ETH. It has been shown that Fe2+ and Cu2+ ions inhibit the enzyme, and the inhibition degree is different at norm and under toxic
hepatitis
. Ca2+ ions insignificantly activate cytosolic NAD-
MDH
under pathology and do not influence the mitochondrial isoform.
...
PMID:[Comparative characterization of catalytic properties of mitochondrial and cytoplasmic forms of NAD-dependent malate dehydrogenase from the rat liver at norm and in toxic hepatitis]. 2000 Jan 26